Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Fludioxonil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00947
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Fungicide |
DME Modulation |
Fludioxonil up-regulates the expression of DME GPX1 |
[1] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
Acrylamide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01187
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Acrylamide inhibits the expression of DME GPX1 |
[2] |
Chloropicrin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Chloropicrin inhibits the expression of DME GPX1 |
[3] |
Cordycepin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01259
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Cordycepin inhibits the expression of DME GPX1 |
[4] |
Formaldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde up-regulates the expression of DME GPX1 |
[5] |
Mercury |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01509
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Mercury up-regulates the expression of DME GPX1 |
[6] |
Ochratoxin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Ochratoxin A induces the drug-metabolizing activity of DME GPX1 |
[7], [8] |
Paraquat |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01422
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Paraquat induces the drug-metabolizing activity of DME GPX1 |
[9] |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Leptomycin B |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00906
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cytotoxin |
DME Modulation |
Leptomycin B up-regulates the expression of DME GPX1 |
[10] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME GPX1 |
[11] |
Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Ethyl methanesulfonate up-regulates the expression of DME GPX1 |
[5] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME GPX1 |
[12] |
Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Pterostilbene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01441
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Environmental Pollutant |
DME Modulation |
Pterostilbene up-regulates the expression of DME GPX1 |
[13] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Perfluorooctane sulfonic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00921
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health and Environmental Toxicant |
DME Modulation |
Perfluorooctane sulfonic acid inhibits the expression of DME GPX1 |
[14] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Amphibole asbestos |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00995
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Mixture |
DME Modulation |
Amphibole asbestos inhibits the drug-metabolizing activity of DME GPX1 |
[15] |
Coal tar |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00755
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Coal tar up-regulates the expression of DME GPX1 |
[16] |
Vitallium |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01511
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Vitallium inhibits the expression of DME GPX1 |
[17], [18] |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Biochanin A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01222
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Biochanin A inhibits the expression of DME GPX1 |
[19] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tea extracts |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01592
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Plant Extract |
DME Modulation |
Tea extracts up-regulates the expression of DME GPX1 |
[20] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 21 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME GPX1 |
[21] |
Aminoglutethimide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00233
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Aminoglutethimide induces the drug-metabolizing activity of DME GPX1 |
[22] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide inhibits the drug-metabolizing activity of DME GPX1 |
[23] |
Auranofin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00270
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Auranofin induces the drug-metabolizing activity of DME GPX1 |
[24] |
Bosentan |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00148
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Bosentan inhibits the expression of DME GPX1 |
[25] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME GPX1 |
[26] |
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the expression of DME GPX1 |
[27] |
Daunorubicin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00351
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Daunorubicin up-regulates the expression of DME GPX1 |
[28], [29] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride induces the drug-metabolizing activity of DME GPX1 |
[30] |
Dronabinol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00115
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dronabinol induces the drug-metabolizing activity of DME GPX1 |
[31] |
Estradiol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol inhibits the expression of DME GPX1 |
[32] |
Etoposide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00121
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Etoposide up-regulates the expression of DME GPX1 |
[33] |
Fluorouracil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00037
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fluorouracil up-regulates the expression of DME GPX1 |
[34] |
Hydrogen peroxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydrogen peroxide inhibits the drug-metabolizing activity of DME GPX1 |
[35] |
Methotrexate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Methotrexate up-regulates the expression of DME GPX1 and leads to increasing the drug-metabolizing activity of this enzyme |
[36] |
Omacor |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00194
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Omacor up-regulates the expression of DME GPX1 |
[37] |
Pyridostigmine bromide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00100
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Pyridostigmine bromide inhibits the expression of DME GPX1 |
[38] |
Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin inhibits the drug-metabolizing activity of DME GPX1 |
[39] |
Troglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Troglitazone up-regulates the expression of DME GPX1 |
[40] |
Rotenone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00481
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Rotenone up-regulates the expression of DME GPX1 |
[41] |
Silver nitrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00511
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Silver nitrate up-regulates the expression of DME GPX1 |
[42] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Epigallocatechin gallate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Epigallocatechin gallate inhibits the expression of DME GPX1 |
[43] |
Fenretinide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00565
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Fenretinide induces the drug-metabolizing activity of DME GPX1 |
[44] |
Resveratrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Resveratrol up-regulates the expression of DME GPX1 |
[45] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME GPX1 and leads to decreasing the drug-metabolizing activity of this enzyme |
[46] |
Genistein |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Genistein up-regulates the expression of DME GPX1 |
[47] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 4 Xenobiotics
|
Homocysteine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01331
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Homocysteine inhibits the drug-metabolizing activity of DME GPX1 |
[48] |
NS-398 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00583
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
NS-398 up-regulates the expression of DME GPX1 |
[49] |
Thioctic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01483
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Thioctic acid induces the drug-metabolizing activity of DME GPX1 |
[50] |
Thiomalates |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00655
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Thiomalates up-regulates the expression of DME GPX1 |
[51] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Emodin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00692
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
Emodin up-regulates the expression of DME GPX1 |
[52] |
Iodoacetate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00696
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug in Preclinical Study |
DME Modulation |
Iodoacetate inhibits the drug-metabolizing activity of DME GPX1 |
[53] |
AM-251 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01194
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
AM-251 up-regulates the expression of DME GPX1 |
[54] |
Drug Marketed but Withdrawn from Market |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Nimesulide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00519
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but Withdrawn from Market |
DME Modulation |
Nimesulide inhibits the expression of DME GPX1 |
[55], [56] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Indirubin-3'-monoxime |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01342
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Indirubin-3'-monoxime inhibits the expression of DME GPX1 |
[57] |
SB-431542 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01147
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
SB-431542 induces the drug-metabolizing activity of DME GPX1 |
[58] |
Other Chemical Compound(s) or Element(s) |
Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Aluminum |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00839
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Chemical Compound |
DME Modulation |
Aluminum inhibits the drug-metabolizing activity of DME GPX1 |
[59] |
|
|
|
|
|
|